293b cpd has been researched along with tolbutamide in 1 studies
| Studies (293b cpd) | Trials (293b cpd) | Recent Studies (post-2010) (293b cpd) | Studies (tolbutamide) | Trials (tolbutamide) | Recent Studies (post-2010) (tolbutamide) |
|---|---|---|---|---|---|
| 100 | 0 | 16 | 5,368 | 238 | 265 |
| Protein | Taxonomy | 293b cpd (IC50) | tolbutamide (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.392 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerlach, U; Heitzmann, D; Lang, F; Ranta, F; Ris, F; Rösler, M; Su, J; Ullrich, S; Warth, R; Wittekindt, OH | 1 |
1 other study(ies) available for 293b cpd and tolbutamide
| Article | Year |
|---|---|
Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells.
Topics: 4-Aminopyridine; Animals; Cell Line, Tumor; Chromans; Gene Expression; Insulin; Insulin Secretion; Insulin-Secreting Cells; KCNQ1 Potassium Channel; Membrane Potentials; Rats; Sulfonamides; Tetraethylammonium; Tolbutamide | 2005 |